1. Home
  2. PDEX vs INDP Comparison

PDEX vs INDP Comparison

Compare PDEX & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pro-Dex Inc.

PDEX

Pro-Dex Inc.

HOLD

Current Price

$67.26

Market Cap

197.4M

Sector

Health Care

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$1.09

Market Cap

171.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDEX
INDP
Founded
1978
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.4M
171.9M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
PDEX
INDP
Price
$67.26
$1.09
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$56.00
N/A
AVG Volume (30 Days)
84.1K
91.2K
Earning Date
05-01-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
345.00
N/A
EPS
3.27
N/A
Revenue
$66,593,000.00
N/A
Revenue This Year
$7.22
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.40
N/A
Revenue Growth
23.68
N/A
52 Week Low
$23.52
$0.92
52 Week High
$68.99
$8.57

Technical Indicators

Market Signals
Indicator
PDEX
INDP
Relative Strength Index (RSI) 61.57 28.22
Support Level $54.15 $0.92
Resistance Level $68.53 $3.05
Average True Range (ATR) 3.30 0.23
MACD 1.04 -0.05
Stochastic Oscillator 85.41 0.89

Price Performance

Historical Comparison
PDEX
INDP

About PDEX Pro-Dex Inc.

Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Share on Social Networks: